Emergent BioSolutions Expands Naloxone Access Through National Awareness Campaign
Event summary
- Emergent BioSolutions partners with Victoria’s Voice Foundation for National Naloxone Awareness Day on June 6, 2026.
- Company supports the 'Shine. Wear. Share. Care.' campaign, distributing NARCAN® Nasal Spray and promotional items.
- Emergent introduces a new NARCAN® Nasal Spray Carrying Case to improve accessibility.
- Ready to Rescue initiative to expand to colleges and universities this fall, led by spokesperson Zac Clark.
- Emergent holds exclusive commercial rights to distribute KLOXXADO® Nasal Spray 8 mg, complementing its NARCAN® product line.
The big picture
Emergent BioSolutions is leveraging strategic partnerships to bolster its position in the opioid reversal market, aligning with broader public health initiatives. The company’s focus on expanding naloxone access reflects the growing demand for overdose prevention tools amid the ongoing opioid epidemic. With exclusive rights to KLOXXADO® and a robust NARCAN® product line, Emergent is well-positioned to capitalize on regulatory and market trends favoring overdose preparedness.
What we're watching
- Market Expansion
- How Emergent’s partnership with Victoria’s Voice Foundation will affect naloxone accessibility in underserved communities.
- Regulatory Alignment
- Whether Emergent can sustain momentum from the White House’s 2026 National Drug Control Strategy.
- Product Innovation
- The pace at which Emergent introduces new naloxone delivery solutions to maintain market leadership.
Related topics